Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 4:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1849–1872 of 6,923 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Depression
Interventions: Deep Brain Stimulations for Depression; Device
Lead sponsor: Ali Rezai, MD; Other
Eligibility: 18 Years to 55 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Isolated Cervical Dystonia
Interventions: Transcranial Magnetic Stimulation (TMS), Placebo, trihexyphenidyl 10mg; Device · Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Knee Arthroplasty
Interventions: Femoral nerve block, Femoral nerve block non stimulating catheter, Femoral nerve block stimulating catheter; Procedure
Lead sponsor: Chicago Anesthesia Pain Specialists; Other
Eligibility: 18 Years to 90 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Major Depressive Disorder
Interventions: TMS with Neurostar TMS Therapy System; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 15 Years to 24 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Atrial Fibrillation, Hypertension
Interventions: catheter ablation, renal sympathetic denervation; Procedure
Lead sponsor: Meshalkin Research Institute of Pathology of Circulation; Network
Eligibility: 18 Years to 75 Years
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Short Hills, New Jersey

Conditions: Traumatic Brain Injury, Concussion, Mild, Depressive Symptoms
Interventions: Active: rTMS, Sham: rTMS; Device
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years to 64 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Bethesda, Maryland • Fort Belvoir, Virginia

Conditions: Bone Marrow Failure Syndrome
Interventions: Filgrastim, Plerixafor, Leukapheresis; Drug · Procedure
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 18 Years to 25 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Gastroesophageal Reflux Disease (GERD), Reflux, Gastroesophageal, Gastroesophageal Reflux, Acid Reflux
Interventions: Laparoscopic implantation surgery with or without crural repair, EndoStim stimulation for first six months of study, EndoStim stimulation from Month 6 thru end of study, Sham EndoStim stimulation for first six months of study; Procedure · Device
Lead sponsor: EndoStim Inc.; Industry
Eligibility: 22 Years to 75 Years
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 18
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Los Angeles, California + 13 more

Conditions: Alzheimer Disease
Interventions: Standard Environmental Design, Individual Environmental Design, Placebo; Behavioral
Lead sponsor: Elizabeth K Rhodus; Other
Eligibility: 21 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma
Interventions: aldesleukin, filgrastim, cyclophosphamide, etoposide, radiation therapy, peripheral blood stem cell transplantation, bone marrow ablation with stem cell support; Biological · Drug · Radiation + 1 more
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 16 Years to 60 Years
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1995
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Schizophrenia, Cerebellar Function, Condition
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer
Interventions: filgrastim, cyclophosphamide, doxorubicin hydrochloride, paclitaxel, tamoxifen citrate, adjuvant therapy, radiation therapy; Biological · Drug · Procedure + 1 more
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2012
U.S. locations: 3
States / cities: Cleveland, Ohio • Mentor, Ohio • Orange, Ohio

Conditions: Acute Neurological Injury, Acute Medical Conditions
Interventions: Auricular Vagus Nerve Stimulation, Sham Auricular Vagus nerve Stimulation; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Diminished Ovarian Reserve, IVF, G-CSF, Granulocyte Colony Stimulating Factor
Interventions: Neupogen 300 μg subcutaneous injection, Subcutaneous injections of a saline solution; Drug · Other
Lead sponsor: Center for Human Reproduction; Other
Eligibility: 35 Years to 44 Years · Female only
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: New York, New York

Conditions: Leukemia
Interventions: CLAG Regimen, Gleevec®; Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Postoperative Pain
Interventions: Ultrasound imaging, Peripheral nerve stimulator; Device
Lead sponsor: Halyard Health; Industry
Eligibility: 18 Years and older
Enrollment: 1,821 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 16
States / cities: Chandler, Arizona • San Jose, California • Louisville, Colorado + 13 more

Conditions: Borderline Personality Disorder (BPD)
Interventions: TMS, D-Cycloserine (DCS); Device · Drug
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Major Depressive Disorder
Interventions: Active - HD tDCS, Sham - HD tDCS; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 65 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Anemia, Leukemia, Neutropenia, Thrombocytopenia
Interventions: filgrastim, leridistim, cytarabine, daunorubicin hydrochloride; Biological · Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 55 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2000
U.S. locations: 1
States / cities: New York, New York

Conditions: Pediatric Stroke, Cerebral Palsy, Chronic Hemiparesis
Interventions: Repetitive Transcranial Magnetic Stimulation, Sham Repetitive Transcranial Magnetic Stimulation, Occupational Therapy; Device · Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 10 Years to 20 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Depression, Major Depressive Episode, Bipolar Disorder
Interventions: MagVenture MagPro MST, RUL ECT; Device · Biological
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 55 Years to 90 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Low-back Pain
Interventions: TENS; Device
Lead sponsor: University of Hartford; Other
Eligibility: 18 Years to 60 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: West Hartford, Connecticut

Conditions: Glaucoma, Glaucoma, Open-Angle
Interventions: Repetitive, Transorbital Alternating Current Stimulation (rtACS), Sham Repetitive, Transorbital Alternating Current Stimulation (rtACS); Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Palo Alto, California • New York, New York • Philadelphia, Pennsylvania

Conditions: Spinal Cord Injury
Interventions: robotic training, spinal cord electrical stimulation, treadmill; Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 65 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Feasibility, Safety and Efficacy of Deep Brain Stimulation for Depression

Accelerating TMS for Cervical Dystonia

Three Different Approaches for Ultrasound Guided Femoral Nerve Block for Patients Undergoing Total Knee Arthroplasty

rTMS for Adolescents and Young Adults

Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation

fMRI-neuronavigated rTMS Treatment for Symptoms of Depression Associated With Concussive TBI in the Military Population

Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders

An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux

Environmental Design for Behavioral Regulation in People With Dementia

Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study

Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes

Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU

Study of G-CSF for DOR in Patients Undergoing IVF

CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)

Multicenter Continuous Peripheral Nerve Block Surveillance Study

A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder

Transcranial Direct Current Stimulation (tDCS) Therapy in Major Depression

Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia

Repetitive TMS and Occupational Therapy in Children and Young Adults With Chronic Hemiparesis

Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults

Transcutaneous Electrical Nerve Stimulation (TENS) and Low Back Pain

Electrical Stimulation for the Treatment of Glaucoma

Improve Dynamic Lateral Balance of Humans With SCI